Skip to main content
. Author manuscript; available in PMC: 2016 Apr 25.
Published in final edited form as: Breast Cancer Res Treat. 2013 Oct 25;142(1):45–57. doi: 10.1007/s10549-013-2733-5

Figure 1. B/I and common γ-c cytokines expand and reprogram PBMCs.

Figure 1

A) Log number of PBMCs determined by trypan blue exclusion before (baseline) and after six days of ex vivo expansion (Reprogrammed; n=16). B) Frequency of Tm cells in baseline PBMCs as wells as reprogrammed PBMCs (n=5). C) Frequency of total CD4+ and CD8+ cells was determined in baseline as well as reprogrammed PBMCs (n=5). D) Frequency of CD25+ CD56+ NK cells (left panel, n=6) and CD25+ CD161+ NK cells (right panel, n=4) in baseline PBMCs or reprogrammed PBMCs. E) Frequency of CD25+ CD56+ NKT cells (left panel, n=6) and CD25+ CD161+ NKT cells (right panel, n=4) in baseline or reprogrammed PBMCs. Data represent Mean ± SEM.